Factors Affecting Mortality in Patients with Blood-Culture Negative Infective Endocarditis
04 February 2020 (online)
Infective endocarditis retains high morbidity and mortality rates despite recent advances in diagnostics, pharmacotherapy, and surgical intervention. Risk stratification in endocarditis patients, including blood-culture negative endocarditis, is crucial in deciding the optimal management strategy; however, the studies investigating risk stratification in these patients were lacking despite the difference with blood-culture positive endocarditis. The aim of this study is to identify risk factors associated with in-hospital mortality in blood-culture negative infective endocarditis patients. A retrospective cohort study was conducted at National Cardiovascular Center Harapan Kita, Jakarta in blood-culture negative infective endocarditis patients from 2013 to 2015. Patient characteristics, clinical parameters, echocardiographic parameters, and clinical complications were collected from medical records and hospital information systems. There were 146 patients that satisfy the inclusion and exclusion criteria out of 162 patients with blood-culture infective endocarditis. The in-hospital mortality rate was 13.5%. On bivariate analyses, factors that were related to in-hospital mortality include New York Heart Association (NYHA) class III and IV heart failure (p = 0.007), history of hypertension (p = 0.021), stroke during hospitalization (p < 0.001), the decline in renal function (p < 0.001), and surgery (p = 0.028). Variables that were independently associated with mortality upon multivariate analysis were heart failure NYHA functional class III and IV (OR 7.56, p = 0.011), worsening kidney function (OR 10.23, p < 0.001), and stroke during hospitalization (OR 8.92, p = 0.001). Presence of heart failure with NYHA functional class III and IV, worsening kidney function, and stroke during hospitalization were independently associated with in-hospital mortality in blood-culture infective endocarditis patients.
This paper received no specific grant from any funding agency, commercial, or not-for-profit sectors.
The data, available in SPSS v25, used to support the findings of this study are available from the corresponding author upon reasonable request.
Ethics Committee of National Cardiovascular Center Harapan Kita provided ethical approval for this study.
- 1 Siddiqui BK, Tariq M, Jadoon A. , et al. Impact of prior antibiotic use in culture-negative endocarditis: review of 86 cases from southern Pakistan. Int J Infect Dis 2009; 13 (05) 606-612
- 2 Siciliano RF, Mansur AJ, Castelli JB. , et al. Community-acquired culture-negative endocarditis: clinical characteristics and risk factors for mortality. Int J Infect Dis 2014; 25: 191-195
- 3 Habib G, Lancellotti P, Antunes MJ. , et al; ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J 2015; 36 (44) 3075-3128
- 4 Katsouli A, Massad MG. Current issues in the diagnosis and management of blood culture-negative infective and non-infective endocarditis. Ann Thorac Surg 2013; 95 (04) 1467-1474
- 5 Baddour LM, Wilson WR, Bayer AS. , et al; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 2015; 132 (15) 1435-1486
- 6 Zamorano J, Sanz J, Moreno R. , et al. Comparison of outcome in patients with culture-negative versus culture-positive active infective endocarditis. Am J Cardiol 2001; 87 (12) 1423-1425
- 7 Hanai M, Hashimoto K, Mashiko K. , et al. Active infective endocarditis: management and risk analysis of hospital death from 24 years' experience. Circ J 2008; 72 (12) 2062-2068
- 8 Jassal DS, Neilan TG, Pradhan AD. , et al. Surgical management of infective endocarditis: early predictors of short-term morbidity and mortality. Ann Thorac Surg 2006; 82 (02) 524-529
- 9 Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: clinical predictors of outcome. Heart 2002; 88 (01) 53-60
- 10 Sastroasmoro S, Madiyono B, Oesman IN, Putra ST. Bacterial endocarditis in children: clinical and laboratory findings, and the role of echocardiography in its diagnosis and management. Paediatr Indones 1989; 29 (9-10): 188-198
- 11 Lopes JA, Jorge S. The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review. Clin Kidney J 2013; 6 (01) 8-14
- 12 Mirabel M, Rattanavong S, Frichitthavong K. , et al. Infective endocarditis in the Lao PDR: clinical characteristics and outcomes in a developing country. Int J Cardiol 2015; 180: 270-273
- 13 Watt G, Lacroix A, Pachirat O. , et al. Prospective comparison of infective endocarditis in Khon Kaen, Thailand and Rennes, France. Am J Trop Med Hyg 2015; 92 (04) 871-874
- 14 Watt G, Pachirat O, Baggett HC. , et al. Infective endocarditis in northeastern Thailand. Emerg Infect Dis 2014; 20 (03) 473-476
- 15 Mirabel M, André R, Barsoum Mikhaïl P. , et al. Infective endocarditis in the Pacific: clinical characteristics, treatment and long-term outcomes. Open Heart 2015; 2 (01) e000183
- 16 Mouly S, Ruimy R, Launay O. , et al. The changing clinical aspects of infective endocarditis: descriptive review of 90 episodes in a French teaching hospital and risk factors for death. J Infect 2002; 45 (04) 246-256
- 17 Fournier PE, Gouriet F, Casalta JP. , et al. Blood culture-negative endocarditis: improving the diagnostic yield using new diagnostic tools. Medicine (Baltimore) 2017; 96 (47) e8392
- 18 Tattevin P, Watt G, Revest M, Arvieux C, Fournier PE. Update on blood culture-negative endocarditis. Med Mal Infect 2015; 45 (1-2): 1-8
- 19 Ferrera C, Vilacosta I, Fernández C. , et al. Reassessment of blood culture-negative endocarditis: its profile is similar to that of blood culture-positive endocarditis. Rev Esp Cardiol (Engl Ed) 2012; 65 (10) 891-900
- 20 Menu E, Gouriet F, Casalta J-P. , et al. Evaluation of empirical treatment for blood culture-negative endocarditis. J Antimicrob Chemother 2017; 72 (01) 290-298